And targeting lncRNA UCA1 induced intratumoral interferon gamma-dependent programmed cell death ligand 1 expression in vivo, thereby synergistically enhancing the anti-bladder cancer activity of immune checkpoint blockade of PD-1 (Zhen et al., 2018). The gene discussed is UCA1; the disease is urinary bladder carcinoma.